Novel device allows 3-D imaging of breast

Novel device allows 3-D imaging of breast with less radiation

New York, June 17 (IANS) Researchers have found a new device that allows for 3-D molecular breast images at higher resolution than current 2-D scans while cutting down the radiation dosages.

The new device called variable angle slant hole collimator or VASH collimator replaces a component in existing molecular breast imagers.

The findings showed that the VASH collimator may enable existing breast cancer imagers to provide up to six times better contrast of tumours in the breast while maintaining the same or better image quality.

Further, the device will also present the precise location (depth information) of the tumour within the breast and significantly reduce the amount of radiation dose to the patient for these procedures.

“These results really focus on the breast. We hope to build on this to perhaps improve the imaging of other organs,” said Drew Weisenberger, from Thomas Jefferson National Accelerator Facility (Jefferson Lab) — a US based research group.

Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer, the researchers said.

The VASH collimator is constructed from a stack of 49 tungsten sheets, each one a quarter of a millimeter thick and containing an identical array of square holes.

The sheets are stacked like a deck of cards, with angled edges on two sides.

Two small motors that slide the individual sheets by their edges can easily slant the angle of the array of square holes in the stack.

Thus, the collimator can be focussed in varying angles during the imaging procedure.

“Now, you can get a whole range of angles of projections of the breast without moving the breast or moving the imager. You are able to come in real close to the breast and can get a one-to-one comparison to a 3D mammogram,” Weisenbeger explained.

The results were presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in San Diego recently.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here